Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-11-06
1984-11-06
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31495
Patent
active
044812019
ABSTRACT:
A pharmaceutical composition intended for the treatment of an acute leukemia which comprises, as the active principle, N,N.sup.3 -di-(.beta.-bromopropionyl)-N.sup.1,N.sup.2 -dispirotripiperazinium dichloride and a pharmaceutically acceptable vehicle therefor. The active principle is used as a lyophilized powder. As the vehicle use is made of an isotonic solution of sodium chloride or distilled water. The content of the active principle in the pharmaceutical composition for injections is 2 to 5% by weight.
REFERENCES:
Chemical Abstracts, 77: 88443v, (1972), and the 9th Coll., p. 10114f, (C.sub.18 H.sub.32 d.sub.2 W.sub.4 O.sub.2).
Chernov Vladimir A.
Dorokhova Margarita I.
Levshina, deceased Kira V.
Minakova Sofya M.
Mizeri, administrator Alexandr A.
Goldberg Jerome D.
Vsesojuzny Nauchno-Issledovatelsky Khimoko-Farmasevtichesky Inst
LandOfFree
Pharmaceutical composition containing N,N.sup.3 -di-(.beta.-brom does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing N,N.sup.3 -di-(.beta.-brom, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing N,N.sup.3 -di-(.beta.-brom will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1042056